Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:908367.
doi: 10.1155/2011/908367. Epub 2011 Nov 24.

Evaluation of Cardioprotective Effect of 3,5,3'-Tri-iodo-L-thyronine in Isoproterenol-Induced Cardiotoxicity

Affiliations

Evaluation of Cardioprotective Effect of 3,5,3'-Tri-iodo-L-thyronine in Isoproterenol-Induced Cardiotoxicity

Vinay Mishra et al. Int J Endocrinol. 2011.

Abstract

T(3) (3,5,3'-triiodothyronine) has drawn relatively little attention in relation to cardiovascular (CVS) diseases. The present study was designed to evaluate the cardioprotective action of T(3) in isoproterenol-(ISO-) induced cardiac toxicity. Female Wistar rats were exposed with ISO (100 mg/kg, body weight, subcutaneously) for 2 days at the interval of 24 h followed by T(3) (3 μg/kg, body weight, orally) treatment for 3 days. Positive control rats received only ISO (100 mg/kg, body weight, subcutaneously) for 2 days at the interval of 24 hrs. Control group animals received normal saline as a vehicle. As expected, ISO-induced significant changes were observed in low-density lipoprotein, total cholesterol, ALT, CK-MB to TCK ratio, and prolongation of QT interval in electrocardiogram, which is toward normalization after T(3) treatment. Lower heart weight, upregulation of cardiac myosin heavy chain alpha (MHC-α), and reduced inflammatory cell infiltration, myonecrosis, vacuolar changes, and a trend toward normal cardiac muscle fiber architecture in microscopic examination of cardiac tissue further support the cardioprotective effect of T(3).

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effect of T3 on low-density lipoprotein, values are presented as Mean ± SD, n = 5, **: significant from control group at 1% level (P < 0.01), ##: significant from ISO control at 1% level (P < 0.01), SD: Standard Deviation.
Figure 2
Figure 2
Effect of T3 on ALT, values are presented as Mean ± SD, n = 5, **: significant from control group at 1% level (P < 0.01), ##: significant from ISO control at 1% level (P < 0.01), SD: Standard Deviation.
Figure 3
Figure 3
Effect of T3 on CKMB: CK Ratio, values are presented as Mean ± SD, n = 5, *: significant from control group at 0.05% level (P < 0.05), #: significant from ISO control group at 0.05% level (P < 0.05), ##: significant from ISO control at 1% level (P < 0.01), SD: Standard Deviation.
Figure 4
Figure 4
Effect of T3 on heart weight. Values are presented as Mean ± SD, n = 5, **: significant from control group at 1% level (P < 0.05), ##: significant from ISO control group at 1% level (P < 0.05), SD: Standard Deviation.
Figure 5
Figure 5
Electrocardiograms.
Figure 6
Figure 6
Effect of T3 on relative expression of MHC-α. Values are presented as Mean ± SD, n = 5, **: significant from control group at 1% level (P < 0.01), SD: Standard Deviation.
Figure 7
Figure 7
Histopathology of cardiac tissue.

Similar articles

References

    1. Lymvaios I, Mourouzis I, Cokkinos DV, Dimopoulos MA, Toumanidis ST, Pantos C. Thyroid hormone and recovery of cardiac function in patients with acute myocardial infarction: a strong association? European Journal of Endocrinology. 2011;165(1):107–114. - PubMed
    1. Pantos C, Dritsas A, Mourouzis I, et al. Thyroid hormone is a critical determinant of myocardial performance in patients with heart failure: potential therapeutic implications. European Journal of Endocrinology. 2007;157(4):515–520. - PubMed
    1. Pantos C, Mourouzis I, Markakis K, et al. Thyroid hormone attenuates cardiac remodeling and improves hemodynamics early after acute myocardial infarction in rats. European Journal of Cardio-thoracic Surgery. 2007;32(2):333–339. - PubMed
    1. Lee SJ, Kang JG, Ryu OK, et al. The relationship of thyroid hormone status with myocardial function in stress cardiomyopathy. European Journal of Endocrinology. 2009;160(5):799–806. - PubMed
    1. Grimm D, Elsner D, Schunkert H, et al. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. Cardiovascular Research. 1998;37(1):91–100. - PubMed